Upstream bio, inc.UPB.US Overview
US StockHealthcare
(No presentation for UPB)
UPB Overall Performance
UPB AI Analysis & Strategy
UPB Recent Performance
0.16%
Upstream bio, inc.
0.81%
Avg of Sector
-1.14%
S&P500
UPB PowerScanner
UPB Key Information
UPB Valuation Metrics
UPB Earnings Table
UPB Profile
Upstream Bio, Inc., a clinical-stage biotechnology company, develops treatments for inflammatory diseases that focuses on severe respiratory disorders. It develops verekitug, a monoclonal antibody that targets and inhibits the thymic stromal lymphopoietin receptor. The company also develops therapies to treat severe asthma, chronic rhinosinusitis with nasal polyps, and chronic obstructive pulmonary disease. Upstream Bio, Inc. was incorporated in 2021 and is based in Waltham, Massachusetts.